T1	Outcomes 1122 1136	the rate of H.
T2	Outcomes 1137 1284	pylori eradication was significantly higher for triple therapy 20/23 cases, 87.0%; 95% confidence interval (CI), 0.664-0.972) than for dual therapy
T3	Outcomes 1355 1406	the difference between the groups in the rate of H.
T4	Outcomes 1407 1452	pylori eradication was marginally significant
T5	Outcomes 1479 1558	Side effects were reported by five patients receiving triple therapy (skin rash
T6	Outcomes 1565 1571	nausea
T7	Outcomes 1578 1586	headache
T8	Outcomes 1593 1607	abdominal pain
T9	Outcomes 1619 1666	four patients receiving dual therapy (skin rash
T10	Outcomes 1673 1687	abdominal pain
T11	Outcomes 1694 1703	diarrhoea
T12	Outcomes 1711 1782	All side effects resolved spontaneously after termination of treatment.
T13	Outcomes 1783 1854	There was no significant difference in safety between the two regimens.
T14	Outcomes 1855 1976	Triple therapy with metronidazole, amoxycillin, and omeprazole was significantly more effective for the eradication of H.
T15	Outcomes 1977 2040	pylori than dual therapy with amoxycillin and omeprazole alone.
